These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 28096331)

  • 1. One-step design of a stable variant of the malaria invasion protein RH5 for use as a vaccine immunogen.
    Campeotto I; Goldenzweig A; Davey J; Barfod L; Marshall JM; Silk SE; Wright KE; Draper SJ; Higgins MK; Fleishman SJ
    Proc Natl Acad Sci U S A; 2017 Jan; 114(5):998-1002. PubMed ID: 28096331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bacterially expressed full-length recombinant Plasmodium falciparum RH5 protein binds erythrocytes and elicits potent strain-transcending parasite-neutralizing antibodies.
    Reddy KS; Pandey AK; Singh H; Sahar T; Emmanuel A; Chitnis CE; Chauhan VS; Gaur D
    Infect Immun; 2014 Jan; 82(1):152-64. PubMed ID: 24126527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Plasmodium falciparum reticulocyte binding protein homologue 5-interacting protein, PfRipr, as a highly conserved blood-stage malaria vaccine candidate.
    Ntege EH; Arisue N; Ito D; Hasegawa T; Palacpac NMQ; Egwang TG; Horii T; Takashima E; Tsuboi T
    Vaccine; 2016 Nov; 34(46):5612-5622. PubMed ID: 27692771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A full-length recombinant Plasmodium falciparum PfRH5 protein induces inhibitory antibodies that are effective across common PfRH5 genetic variants.
    Bustamante LY; Bartholdson SJ; Crosnier C; Campos MG; Wanaguru M; Nguon C; Kwiatkowski DP; Wright GJ; Rayner JC
    Vaccine; 2013 Jan; 31(2):373-9. PubMed ID: 23146673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic polymorphisms in malaria vaccine candidate Plasmodium falciparum reticulocyte-binding protein homologue-5 among populations in Lagos, Nigeria.
    Ajibaye O; Osuntoki AA; Balogun EO; Olukosi YA; Iwalokun BA; Oyebola KM; Hikosaka K; Watanabe YI; Ebiloma GU; Kita K; Amambua-Ngwa A
    Malar J; 2020 Jan; 19(1):6. PubMed ID: 31906953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A malaria vaccine candidate based on an epitope of the Plasmodium falciparum RH5 protein.
    Ord RL; Caldeira JC; Rodriguez M; Noe A; Chackerian B; Peabody DS; Gutierrez G; Lobo CA
    Malar J; 2014 Aug; 13():326. PubMed ID: 25135070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. APC-Targeted DNA Vaccination Against Reticulocyte-Binding Protein Homolog 5 Induces
    Bjerkan L; Visweswaran GRR; Gudjonsson A; Labbé GM; Quinkert D; Pattinson DJ; Spång HCL; Draper SJ; Bogen B; Braathen R
    Front Immunol; 2021; 12():720550. PubMed ID: 34733274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasmodium falciparum merozoite surface antigen, PfRH5, elicits detectable levels of invasion-inhibiting antibodies in humans.
    Patel SD; Ahouidi AD; Bei AK; Dieye TN; Mboup S; Harrison SC; Duraisingh MT
    J Infect Dis; 2013 Nov; 208(10):1679-87. PubMed ID: 23904294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure of malaria invasion protein RH5 with erythrocyte basigin and blocking antibodies.
    Wright KE; Hjerrild KA; Bartlett J; Douglas AD; Jin J; Brown RE; Illingworth JJ; Ashfield R; Clemmensen SB; de Jongh WA; Draper SJ; Higgins MK
    Nature; 2014 Nov; 515(7527):427-30. PubMed ID: 25132548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity of a chimeric Plasmodium falciparum merozoite surface protein vaccine in Aotus monkeys.
    Burns JM; Miura K; Sullivan J; Long CA; Barnwell JW
    Malar J; 2016 Mar; 15():159. PubMed ID: 26975721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production of full-length soluble Plasmodium falciparum RH5 protein vaccine using a Drosophila melanogaster Schneider 2 stable cell line system.
    Hjerrild KA; Jin J; Wright KE; Brown RE; Marshall JM; Labbé GM; Silk SE; Cherry CJ; Clemmensen SB; Jørgensen T; Illingworth JJ; Alanine DG; Milne KH; Ashfield R; de Jongh WA; Douglas AD; Higgins MK; Draper SJ
    Sci Rep; 2016 Jul; 6():30357. PubMed ID: 27457156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extent and Dynamics of Polymorphism in the Malaria Vaccine Candidate
    Ouattara A; Tran TM; Doumbo S; Adams M; Agrawal S; Niangaly A; Nelson-Owens S; Doumtabé D; Tolo Y; Ongoiba A; Takala-Harrison S; Traoré B; Silva JC; Crompton PD; Doumbo OK; Plowe CV
    Am J Trop Med Hyg; 2018 Jul; 99(1):43-50. PubMed ID: 29848401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preclinical development of a stabilized RH5 virus-like particle vaccine that induces improved antimalarial antibodies.
    King LDW; Pulido D; Barrett JR; Davies H; Quinkert D; Lias AM; Silk SE; Pattinson DJ; Diouf A; Williams BG; McHugh K; Rodrigues A; Rigby CA; Strazza V; Suurbaar J; Rees-Spear C; Dabbs RA; Ishizuka AS; Zhou Y; Gupta G; Jin J; Li Y; Carnrot C; Minassian AM; Campeotto I; Fleishman SJ; Noe AR; MacGill RS; King CR; Birkett AJ; Soisson LA; Long CA; Miura K; Ashfield R; Skinner K; Howarth MR; Biswas S; Draper SJ
    Cell Rep Med; 2024 Jul; 5(7):101654. PubMed ID: 39019011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of a P. falciparum specific coiled-coil domain to construct a self-assembling protein nanoparticle vaccine to prevent malaria.
    Karch CP; Doll TAPF; Paulillo SM; Nebie I; Lanar DE; Corradin G; Burkhard P
    J Nanobiotechnology; 2017 Sep; 15(1):62. PubMed ID: 28877692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A PfRH5-based vaccine is efficacious against heterologous strain blood-stage Plasmodium falciparum infection in aotus monkeys.
    Douglas AD; Baldeviano GC; Lucas CM; Lugo-Roman LA; Crosnier C; Bartholdson SJ; Diouf A; Miura K; Lambert LE; Ventocilla JA; Leiva KP; Milne KH; Illingworth JJ; Spencer AJ; Hjerrild KA; Alanine DG; Turner AV; Moorhead JT; Edgel KA; Wu Y; Long CA; Wright GJ; Lescano AG; Draper SJ
    Cell Host Microbe; 2015 Jan; 17(1):130-9. PubMed ID: 25590760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity of a recombinant malaria vaccine candidate, domain I+II of AMA-1 ectodomain, from Indian P. falciparum alleles.
    Lalitha PV; Biswas S; Pillai CR; Saxena RK
    Vaccine; 2008 Aug; 26(35):4526-35. PubMed ID: 18590786
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fusion to Tetrahymena thermophila granule lattice protein 1 confers solubility to sexual stage malaria antigens in Escherichia coli.
    Agrawal A; Bisharyan Y; Papoyan A; Bednenko J; Cardarelli J; Yao M; Clark T; Berkmen M; Ke N; Colussi P
    Protein Expr Purif; 2019 Jan; 153():7-17. PubMed ID: 30081196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacterially expressed and refolded receptor binding domain of Plasmodium falciparum EBA-175 elicits invasion inhibitory antibodies.
    Pandey KC; Singh S; Pattnaik P; Pillai CR; Pillai U; Lynn A; Jain SK; Chitnis CE
    Mol Biochem Parasitol; 2002 Aug; 123(1):23-33. PubMed ID: 12165386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The RH5-CyRPA-Ripr Complex as a Malaria Vaccine Target.
    Ragotte RJ; Higgins MK; Draper SJ
    Trends Parasitol; 2020 Jun; 36(6):545-559. PubMed ID: 32359873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RH5-Basigin interaction plays a major role in the host tropism of Plasmodium falciparum.
    Wanaguru M; Liu W; Hahn BH; Rayner JC; Wright GJ
    Proc Natl Acad Sci U S A; 2013 Dec; 110(51):20735-40. PubMed ID: 24297912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.